pd 98059 and anandamide

pd 98059 has been researched along with anandamide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Petrocellis, L; Di Marzo, V; Galve-Roperh, I; Guzmán, M; Melck, D; Rueda, D1
Milton, NG1

Other Studies

2 other study(ies) available for pd 98059 and anandamide

ArticleYear
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells.
    FEBS letters, 1999, Dec-17, Volume: 463, Issue:3

    Topics: Arachidonic Acids; Breast Neoplasms; Cell Division; Cell Line; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Endocannabinoids; Flavonoids; Humans; Mitogen-Activated Protein Kinases; Nerve Growth Factor; Piperidines; Polyunsaturated Alkamides; Prolactin; Proto-Oncogene Proteins c-raf; Pyrazoles; Receptors, Prolactin; Rimonabant; Tumor Cells, Cultured

1999
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
    Neuroscience letters, 2002, Oct-31, Volume: 332, Issue:2

    Topics: Amyloid beta-Peptides; Arachidonic Acids; Cannabinoids; Corticotropin-Releasing Hormone; Endocannabinoids; Enzyme Inhibitors; Flavonoids; Glycerides; Humans; Mitogen-Activated Protein Kinases; Nervous System Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Oxidation-Reduction; Peptide Fragments; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug

2002